Business · 17/11/2014Updated: 10/17/2026 · 1 min read
FDA Corrects Document on Withdrawn or Removed Drug Products
Summary
The FDA is correcting a document that proposed revising the list of drug products that may not be compounded under certain exemptions due to safety or effectiveness concerns. The document also withdrew a previous proposed rule and corrected an error in the RIN number.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →